AU8191091A - Aspartic protease inhibitors - Google Patents

Aspartic protease inhibitors

Info

Publication number
AU8191091A
AU8191091A AU81910/91A AU8191091A AU8191091A AU 8191091 A AU8191091 A AU 8191091A AU 81910/91 A AU81910/91 A AU 81910/91A AU 8191091 A AU8191091 A AU 8191091A AU 8191091 A AU8191091 A AU 8191091A
Authority
AU
Australia
Prior art keywords
protease inhibitors
aspartic protease
aspartic
inhibitors
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81910/91A
Other languages
English (en)
Inventor
Geoffrey Bainbridge Dreyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU8191091A publication Critical patent/AU8191091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU81910/91A 1990-07-06 1991-07-03 Aspartic protease inhibitors Abandoned AU8191091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54946090A 1990-07-06 1990-07-06
US549460 1990-07-06

Publications (1)

Publication Number Publication Date
AU8191091A true AU8191091A (en) 1992-02-04

Family

ID=24193116

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81910/91A Abandoned AU8191091A (en) 1990-07-06 1991-07-03 Aspartic protease inhibitors

Country Status (4)

Country Link
EP (1) EP0538374A4 (ja)
JP (1) JPH05508846A (ja)
AU (1) AU8191091A (ja)
WO (1) WO1992000954A1 (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007269A1 (en) * 1993-09-10 1995-03-16 Narhex Limited Polar-substituted hydrocarbons
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US6258806B1 (en) 1992-03-11 2001-07-10 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321153A (en) * 1992-06-15 1994-06-14 Monsanto Company Process for making chiral alpha-amino phosphonates selected novel chiral alpha-amino phosphonates
DE4422911A1 (de) * 1994-06-30 1996-01-04 Hoechst Ag Phosphinsäure-Derivate, deren Herstellung sowie deren Verwendung
KR20230038457A (ko) 2020-06-10 2023-03-20 알리고스 테라퓨틱스 인코포레이티드 코로나바이러스, 피코르나바이러스 및 노로바이러스 감염을 치료하기 위한 항바이러스 화합물
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627477A5 (de) * 1977-02-10 1982-01-15 Ciba Geigy Ag Verfahren zur herstellung einer neuen phosphinsaeure und ihrer salze.
CH634968A5 (de) * 1977-04-01 1983-03-15 Ciba Geigy Ag Herbizides und pflanzenwuchsregulierendes mittel enthaltend eine neue phosphinsaeure oder deren salze, ester, amide oder hydrazide sowie verwendung derselben.
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors
ATE159946T1 (de) * 1989-12-16 1997-11-15 Hoechst Ag Inhibitoren retroviraler proteasen

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5942504A (en) * 1992-03-11 1999-08-24 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US6258806B1 (en) 1992-03-11 2001-07-10 Narhex Limited Amine derivatives of oxo- and hydroxy- substituted hydrocarbons
WO1995007269A1 (en) * 1993-09-10 1995-03-16 Narhex Limited Polar-substituted hydrocarbons

Also Published As

Publication number Publication date
EP0538374A4 (en) 1993-05-19
JPH05508846A (ja) 1993-12-09
WO1992000954A1 (en) 1992-01-23
EP0538374A1 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
HU912541D0 (en) Serine protease inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
HU9302080D0 (en) Amine-diole protease inhibitors
AU7775991A (en) Interleukin 1beta protease
ZA917096B (en) Enzyme inhibitors
AU9122391A (en) Hiv protease inhibitors
ZA915269B (en) Retroviral protease inhibitors
HU9202842D0 (en) Climotripsine-type proteases and inhibitors
PL326508A1 (en) Protease inhibitors
IL112759A0 (en) Novel cysteine protease inhibitors
EP0744948A4 (en) PROTEASE INHIBITORS
IL102534A0 (en) Retroviral protease inhibitors
AU5069993A (en) Retroviral protease inhibitors
EP0535092A4 (en) Protease nexin-i variants
IL100161A0 (en) Retroviral protease inhibitors derived from 3-chloro-2-chloro-methyl-1-propene
AU8191091A (en) Aspartic protease inhibitors
AU7131991A (en) Hiv protease inhibiting agents
AU7132391A (en) Hiv protease inhibitors
AU8231391A (en) Inhibitors of aspartic proteases
EP0594586A4 (en) Hiv protease inhibitors
AU3735793A (en) Retroviral protease inhibitors
AU7742691A (en) Novel protease assays
AU645641B2 (en) Babesial protease antigen
GB9007750D0 (en) Enzyme inhibitors
GB9126531D0 (en) Novel protease